Interventions
DISORDER, REINFECTION
This trial will consist of a comparative evaluation of two forms of linkage-to-care among ED patients identified with untreated HCV. The first intervention, The second intervention, Linkage navigators will undergo structured training prior to the start of the trial and will provide follow-up services for up to 18 months from the time of enrollment with a minimum of three attempted contacts for patients who are difficult to reach. For individuals who test negative for HCV RNA, linkage navigators will make no more than three attempts to contact the patient to (1) deliver and explain the RNA results, (2) discuss the risk of reinfection and future testing recommendations, and (3) provide resources for insurance enrollment and substance use disorder treatment, as needed.